BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 29019676)

  • 1. Small Molecule Antagonists of the Interaction between the Histone Deacetylase 6 Zinc-Finger Domain and Ubiquitin.
    Harding RJ; Ferreira de Freitas R; Collins P; Franzoni I; Ravichandran M; Ouyang H; Juarez-Ornelas KA; Lautens M; Schapira M; von Delft F; Santhakumar V; Arrowsmith CH
    J Med Chem; 2017 Nov; 60(21):9090-9096. PubMed ID: 29019676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Structure-Activity Relationship of HDAC6 Zinc-Finger Ubiquitin Binding Domain Inhibitors.
    Ferreira de Freitas R; Harding RJ; Franzoni I; Ravichandran M; Mann MK; Ouyang H; Lautens M; Santhakumar V; Arrowsmith CH; Schapira M
    J Med Chem; 2018 May; 61(10):4517-4527. PubMed ID: 29741882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6.
    Harding RJ; Franzoni I; Mann MK; Szewczyk MM; Mirabi B; Ferreira de Freitas R; Owens DDG; Ackloo S; Scheremetjew A; Juarez-Ornelas KA; Sanichar R; Baker RJ; Dank C; Brown PJ; Barsyte-Lovejoy D; Santhakumar V; Schapira M; Lautens M; Arrowsmith CH
    J Med Chem; 2023 Aug; 66(15):10273-10288. PubMed ID: 37499118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics of zinc-finger ubiquitin binding domains: a comparative study of histone deacetylase 6 and ubiquitin-specific protease 5.
    Dos Santos Passos C; Simões-Pires CA; Carrupt PA; Nurisso A
    J Biomol Struct Dyn; 2016 Dec; 34(12):2581-2598. PubMed ID: 26619262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDAC6 ZnF UBP as the Modifier of Tau Structure and Function.
    Balmik AA; Chidambaram H; Dangi A; Marelli UK; Chinnathambi S
    Biochemistry; 2020 Dec; 59(48):4546-4562. PubMed ID: 33237772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of Unanchored Polyubiquitin Chains from Influenza Virions.
    Miyake Y; Matthias P; Yamauchi Y
    Methods Mol Biol; 2018; 1836():329-342. PubMed ID: 30151581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoprecipitation of HDAC6 and Interacting Proteins.
    Wang L; Sanchez J; Hess D; Matthias P
    Methods Mol Biol; 2023; 2589():493-508. PubMed ID: 36255645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and Crystallization of HDAC6 Tandem Catalytic Domains.
    Langousis G; Sanchez J; Kempf G; Matthias P
    Methods Mol Biol; 2023; 2589():467-480. PubMed ID: 36255643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the non-enzymatic function of HDAC6.
    Zhu Y; Feng M; Wang B; Zheng Y; Jiang D; Zhao L; Mamun MAA; Kang H; Nie H; Zhang X; Guo N; Qin S; Wang N; Liu H; Gao Y
    Biomed Pharmacother; 2023 May; 161():114438. PubMed ID: 37002569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention.
    Bertos NR; Gilquin B; Chan GK; Yen TJ; Khochbin S; Yang XJ
    J Biol Chem; 2004 Nov; 279(46):48246-54. PubMed ID: 15347674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of the first small molecule histone deacetylase 6 (HDAC6) degraders.
    Yang K; Song Y; Xie H; Wu H; Wu YT; Leisten ED; Tang W
    Bioorg Med Chem Lett; 2018 Aug; 28(14):2493-2497. PubMed ID: 29871848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Expression and Functions of Histone Deacetylase 6 (HDAC6).
    Li M; Zhuang Y; Shan B
    Methods Mol Biol; 2016; 1436():85-94. PubMed ID: 27246209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Small Molecule Antagonists of the USP5 Zinc Finger Ubiquitin-Binding Domain.
    Mann MK; Franzoni I; de Freitas RF; Tempel W; Houliston S; Smith L; Vedadi M; Arrowsmith CH; Harding RJ; Schapira M
    J Med Chem; 2019 Nov; 62(22):10144-10155. PubMed ID: 31663737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for the expression, purification, and crystallization of histone deacetylase 6-inhibitor complexes.
    Osko JD; Christianson DW
    Methods Enzymol; 2019; 626():447-474. PubMed ID: 31606087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
    Porter NJ; Mahendran A; Breslow R; Christianson DW
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):13459-13464. PubMed ID: 29203661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.
    Osko JD; Christianson DW
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127023. PubMed ID: 32067866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupting the HDAC6-ubiquitin interaction impairs infection by influenza and Zika virus and cellular stress pathways.
    Wang L; Moreira EA; Kempf G; Miyake Y; Oliveira Esteves BI; Fahmi A; Schaefer JV; Dreier B; Yamauchi Y; Alves MP; Plückthun A; Matthias P
    Cell Rep; 2022 Apr; 39(4):110736. PubMed ID: 35476995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophore-based virtual screening for identification of potential selective inhibitors of human histone deacetylase 6.
    Uba AI; Yelekçi K
    Comput Biol Chem; 2018 Dec; 77():318-330. PubMed ID: 30463049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.
    Tan Y; Ci Y; Dai X; Wu F; Guo J; Liu D; North BJ; Huo J; Zhang J
    Oncotarget; 2017 Jul; 8(29):47890-47901. PubMed ID: 28599312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
    Uba AI; Yelekçi K
    Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.